October 22, 2021

Dr. Johns interviewed by Healio

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

READ THE HEALIO ARTICLE
The Latest
Experiences With Unionization Among General Surgery Resident Physicians, Faculty, and Staff
Influence

Experiences With Unionization Among General Surgery Resident Physicians, Faculty, and Staff

Dr. Gonzalez: Creating a code of conduct for use of AI in healthcare
Video

Dr. Gonzalez: Creating a code of conduct for use of AI in healthcare

Regenstrief to host semiannual LOINC® conference in Washington, D.C., Sept. 17-20
News

Regenstrief to host semiannual LOINC® conference in Washington, D.C., Sept. 17-20

Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial
Influence

Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

Ensuring use of AI to improve health meets its full potential reliably and safely
News

Ensuring use of AI to improve health meets its full potential reliably and safely

$15.5 million NIH award funds development of national network to include nursing home residents in clinical trials
News

$15.5 million NIH award funds development of national network to include nursing home residents in clinical trials